Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-033740
Filing Date
2024-07-31
Accepted
2024-07-31 16:02:17
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abt-20240630.htm   iXBRL 10-Q 1425765
2 EX-31.1 q2202410qex311.htm EX-31.1 9492
3 EX-31.2 q2202410qex312.htm EX-31.2 9470
4 EX-32.1 q2202410qex321.htm EX-32.1 5185
5 EX-32.2 q2202410qex322.htm EX-32.2 4986
  Complete submission text file 0001628280-24-033740.txt   8235007

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abt-20240630.xsd EX-101.SCH 46045
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abt-20240630_cal.xml EX-101.CAL 68498
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abt-20240630_def.xml EX-101.DEF 280099
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abt-20240630_lab.xml EX-101.LAB 659783
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abt-20240630_pre.xml EX-101.PRE 456414
80 EXTRACTED XBRL INSTANCE DOCUMENT abt-20240630_htm.xml XML 1532707
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-02189 | Film No.: 241161823
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)